DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.         )

 

 

 

   Filed by the Registrant
   Filed by a Party other than the Registrant

Check the appropriate box:

   Preliminary Proxy Statement
   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   Definitive Proxy Statement
   Definitive Additional Materials
   Soliciting Material under § 240.14a-12

Biodesix, Inc.

 

(Name of Registrant as Specified in its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

   No fee required.
   Fee paid previously with preliminary materials.
   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.


LOGO

P.O. BOX 8016, CARY, NC 27512-9903

Biodesix, Inc.

Important Notice Regarding the Availability

of Proxy Materials

for the

Stockholders Meeting to be held on May 23, 2023

For Stockholders of record as of March 24, 2023

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

To view the proxy materials, including the Notice and Proxy Statement, Annual Report on Form 10-K, and to obtain directions to attend the meeting, go to: www.proxydocs.com/BDSX

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.

 

 

    

 

 
 

 

LOGO     

  

For a convenient way to view proxy materials and VOTE go to

www.proxydocs.com/BDSX

 

Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions.

 

  

     LOGO

           
  

 

If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before May 12, 2023.

  
     To order paper materials, use one of the following methods.     

 

    

 

 

 

LOGO

 

INTERNET

www.investorelections.com/BDSX

 

 

 

    

 

 

LOGO

TELEPHONE

      (866) 648-8133      

 

 

 

    

 

 

LOGO

* E-MAIL

    [email protected]    

 

 

 

    

 

           
 

When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above.

  * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.  

 

 

 

Biodesix, Inc.

 

 

    

    

 

Meeting Type:   Annual Meeting of Stockholders

 
 

Date:   Tuesday, May 23, 2023

 
 

Time:   1:00 PM, Mountain Time

 
 

Place:   Annual Meeting to be held live via the Internet - please visit

www.proxydocs.com/BDSX for more details.

 
 
 

You must register to attend the meeting online and/or participate at www.proxydocs.com/BDSX

 
 
 

SEE REVERSE FOR FULL AGENDA

    

 


Biodesix, Inc.

Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

FOR ON PROPOSALS 1, 2 AND 3

 

  

PROPOSAL

 

1.

To elect the three Class III directors to hold office until the 2026 annual meeting of stockholders;

1.01 Jean M. Franchi

1.02 Hany Massarany

1.03 Jack Schuler

 

2.

To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2023;

 

3.

To approve the option exchange program; and

 

4.

To conduct any other business properly brought before the meeting, or any adjournment or postponement thereof.